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In order to indicate how the clinical microbiology laboratory
functions in a Swiss university hospital, a description of the
services provided by the University Hospital in Lausanne will
be used.This hospital (1000 beds) is a primary, secondary and
tertiary institution serving a population of 500 000 inwestern
Switzerland. It covers all medical and surgical specialities,
including transplantation (kidney, liver, heart, and lungs), and
has an HIV clinic. The division of infectious diseases is well
developed, with about 20 beds. Its sta¡ are responsible, as pri-
mary care physicians, for hospitalized hemato-oncologic
patients, including those receiving autologous bone marrow
transplants.
The clinical microbiology laboratory is part of a depart-
ment of laboratory medicineötogether with clinical chemis-
try and hematology. It is made up of several sections
(bacteriology/mycology, serology, virology, mycobacteriol-
ogy, parasitology, and molecular diagnostic) located in the
main hospital building. The clinical microbiology laboratory
handles over 100 000 specimens/year, with over 60% of them
in the bacteriology section.
Rapid and safe transport of the potentially infectious clini-
cal material is essential. Medically precious materials (CSF,
surgically obtained samples) are hand delivered bydirect cour-
ier to the laboratory. Emergency specimens, other than those
in glass containers, are carefully wrapped in leakproof sealed
plastic bags, and sent to the laboratory by pneumatic post. For
non-emergency specimens and specimens in containers made
of glass, a regular collection round for all wards and clinics
occurs twice or three times a day.
The bacteriology laboratory is open 7 days a week, from 8
a.m. to 6 p.m. At night, an experienced on-call technologist is
available for emergency specimens such as CSF samples from
patients with suspicion of meningitis, bronchoscopic lower
respiratory tract specimens from patients with nosocomial
pneumonia, surgically obtained materials, or serologic testing
for transplant patients.Within the limitations of one shift per
24 h, the clinical bacteriology laboratory is organized to pro-
vide rapid, relevant and clinically useful services. To achieve
this goal, the following measures/procedures have been
implemented (Table1):
1. A central accession desk is linked to a computer informa-
tion system common to all major laboratories (LIS) and to the
general hospital information system (HIS). This allows rapid
checks on the nature of the request and specimen, and comple-
tion of missing information. Several quality-oriented rejec-
tion criteria are applied to specimens, such as time since
sampling, and appropriateness of the material relevant to the
test(s) requested. For specimens considered unacceptable, a
document is issued immediately on the computer system or a
phone call is made to the requester.
2. The continuous handling of incoming specimens reduces
the time between sampling and laboratory handling, reduces
the turn-round time (TAT) for communicating the results of
direct specimen examination, separates the specimens
intended for di¡erent laboratories without loss of time, and
speeds all subsequent steps and procedures as a result of
prompt inoculation on primary culture media.
3. The systematic application of quality-oriented rejection
criteria allows us signi¢cantly to reduce the overall number of
specimens examined and thus the overall cost. Examples of
such screening are a rejection rate for sputum Gram stain of
40%, rejection of requests for mycobacterial culture on CSF
samples lacking an increase inwhite cells when collected from
a non-neutropenic, non-AIDS patient, and requests for stool
culture for enteric pathogens in patients hospitalized for more
than 3 days in the absence of an epidemic problem. Additional
restrictions are placed on cultures from sites close to the gas-
trointestinal tract where the Gram stain shows a mixed fecal
£ora, anaerobic cultures of sites contiguous to a mucosal sur-
face, bacterial culture for vaginitis, and antibiotic susceptibil-
ity testing for organisms without well-de¢ned breakpoints or
methods.
4. To provide assurance of aTATof 60min for issuing a result
of direct examination of important specimens (most often by
Gram stain), notably normally sterile body £uids, tissue biop-
sies, lower respiratory tract specimens, surgical specimens
taken in the operating room, as well as fresh uncentrifuged
urines. These rapid preliminary results have an impact on the
initiation or modi¢cation of empirical anti-infective treat-
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ment. All highly signi¢cant results are phoned to the primary
care physician and/or to the infectious disease consultant.
5. The processing of bacteriology cultures (reading, identi¢-
cation and susceptibility testing) are grouped by type of
patient (medical services, surgical services, mother^ infant)
rather than by type of specimen (urines, sputa, pus, etc.) This
allows the same technologist to simultaneously process all spe-
cimens from a given patient, and greatly facilitates the com-
parison of di¡erent culture results. A synthesis of the various
investigations by the supervisor and the infectious disease con-
sultant is greatly facilitated by this approach.
6. Special sections deal with automated blood culture moni-
toring and samples from immunocompromised patients
(onco-hematology, transplant) requiring multiple testing,
such as special stains or direct immuno£uorescence, and fun-
gal antigen detection.
7. Direct and rapid antibiotic susceptibility testing and some-
times identi¢cation are undertaken for all signi¢cant isolates
recovered for the ¢rst time from blood cultures or other nor-
mally sterile body £uids (e.g. CSF, joint £uids), mostly to
detect resistance (or resistance mechanism) to drugs which
might otherwise be used as empirical therapy. It is widely
recognized that the early detection of resistance is far more
important than that of susceptibility [1,2]. Automated instru-
ments for rapid identi¢cation and susceptibility testing
equipped with built-in systems for the detection of mechan-
isms of resistancewill play an increasing role in the future.
8. Mycology is not separated from bacteriology, because
experience has taught us that the majority of positive signi¢-
cant results for yeasts and fungi are made on specimens sent
with a request for bacteriology and not for mycology.
9. Antibiotic susceptibility test results carried out on a limited
number of organisms for a limited number of clinical settings
are reported to the clinicians; this only identi¢es drugs
authorized for use by the hospital. Results are usually pre-
sented qualitatively (susceptible or resistant) rather than quan-
titatively (MIC or zone sizes). Statistics on susceptibility by
organism are made available on a regular basis to the clini-
cians.
10. A molecular diagnostic unit carries out an increasingly
broader range of tests (Table 2) [3]. Except for a few, all
requests are initially discussed between the clinician and a sta¡
member of the microbiology laboratory. This service con-
sumes an increasing proportion of the laboratory resources,
such that it is mandatory that the results and bene¢t for the
patient are regularly carefully evaluated.
Good two-way communication between clinicians and
laboratory sta¡ is of utmost importance. Clinicians should
identify and mention factors and conditions which will direct
the management of microbiological investigations, while
clinical microbiologists should inform clinicians about
changes in nomenclature, interpretation criteria, and the
introduction of new or modi¢ed tests, and assist in the inter-
pretation of the results they generate.To do so, we have imple-
mented the followingmeasures in our hospital (Table 3):
Table 1 Procedures which provide rapid and clinically useful laboratory services
Procedures
Central accession desk
Continuous handling of specimens
Quality-oriented rejection criteria and screening for negative samples
Turn-around time for key procedures
Benches organized by clinical services
Rapid and direct identi®cation and susceptibility testing on most clinically signi®cant specimens
Restricted antibiotic susceptibility testing reported to non-infectious diseases doctors
Molecular diagnosis available for a broad range of pathogens on special request
Table 2 Tests performed in the molecular microbiology laboratory
Commercial tests (PCR) Home-made tests
Mycobacterium tuberculosis complex Listeria monocytogenes
Bordetella pertussis
Chlamydia trachomatis Bartonella henselae
Neisseria gonorrhoeae Legionella pneumophila
Toxoplasma gondii
Pneumocystis carinii
HIV* Candida albicans
Hepatitis viruses* Cytomegalovirus
Herpes simplex virus 1, 2
Epstein±Barr virus
Varicella zoster virus
JC virus
Papillomaviruses
*Tests performed in the clinical immunology laboratory.
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1. Daily rounds in the laboratory where all signi¢cant results
(often as preliminary ¢ndings) are communicated to infec-
tious disease and infection control consultants who discuss
them in the context of the patient clinical situation.
2. Preliminary results are available on the Laboratory Infor-
mation System (LIS) as soon as they have been validated in the
laboratory.
3. A summary of all microbiological results for a given patient
and hospital stay is continuously updated and available to
authorized physicians either on computer screen or as printed
paper.
4. Cumulative susceptibility testing results, regularly
updated, are distributed to physicians.
5. Suspicious results or those indicative of a nosocomial or
antimicrobial resistance problem are automatically trans-
mitted to the infection control service. A special molecular
epidemiology laboratory has the capacity to investigate in real
time suspicious clusters of nosocomial cases or outbreaks.
Teaching at di¡erent levels is an important task of the mod-
ern clinical microbiology laboratory, in part because clinical
microbiology still relies heavily on human skills and experi-
ences rather than on automated machines. Teaching medical
technologists during their practical stages is essential to main-
tain a high quality level of practical skills and theoretical
knowledge.
A special 3 -year postgraduate course in clinical microbiol-
ogy has been recently implemented in Switzerland for MDs
and/or PhDs. This diagnostic-oriented education consists
mainly of a broad practical exposure to all aspects of the
laboratory diagnosis, prevention and treatment of infectious
diseases.
This formal teaching is complemented by a daily round
between clinical microbiologists and infectious disease con-
sultants, as well as infection control doctors, and by a weekly
case presentation with contributions from clinicians and
laboratory sta¡.
The philosophy behind our laboratory is to place the maxi-
mum emphasis on speed of processing of a restricted number
of tests on specimens often obtained from complicated
patients. To do so, a well-educated and highly motivated sta¡
is required, with a broad interface between clinical needs and
laboratory options. Clinical microbiology will certainly
evolve towards greater automation and molecular testing, but
not to the prejudice of this continuous dialogue and invaluable
communication between clinicians and laboratory sta¡.
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Table 3 Communication and the clinical microbiology laboratory
Communication
Computer system dedicated to laboratory medicine
Bi-directional link with:
General hospital computer system
Automates (blood culture, serology)
Preliminary, progress and ®nal reports
Printed in the wards
To be consulted on screens
Summary microbiology result
Can be looked at or printed by authorized persons (infectious disease staff and infection control persons)
Daily meeting with infectious disease consultants and infection control persons
Communication of all preliminary relevant results
Weekly microbiology±infectious diseases conference
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